Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.

Autoimmune markers may help diagnose and manage PCOS.

PCOS may increase the risk of mental health issues like depression and anxiety.

Gut microbiota and metabolic pathways may play a key role in PCOS development.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

People with polycystic ovary syndrome often experience anxiety and depression.

The AMHR2-482A>G gene change is linked to higher PCOS risk.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

The Oat mouse model shows mild retinal degeneration, useful for testing treatments.

High levels of androgens during early development may cause PCOS-like symptoms.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

Osteopathic manipulation therapy might help treat dementia caused by finasteride.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

ANE syndrome is caused by a mutation in the RBM28 protein that disrupts ribosome assembly.

Early detection, consistent management, and lifestyle changes are crucial for managing HAIR-AN syndrome effectively.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Early investigation of PCOS in high school girls is necessary due to associated risks and side effects.

m6A deregulation plays a key role in PCOS and could lead to new treatments.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

Early recognition and multidisciplinary management of Whitaker syndrome can improve patient outcomes.

Agmatine may help reduce seizures linked to hormone changes in female rats.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

A gene mutation in mice causes hair loss, weak bones, and protein buildup, showing how protein processing issues can lead to diseases.

The document concludes that Polycystic Ovary Syndrome is a commonly underdiagnosed hormonal disorder in women, diagnosed by specific criteria.

Hyperprolactinemia is the most common cause of secondary amenorrhea, followed by drug use.

Indole-based compounds improved ovarian health in rats with PCOS, with L-Tryptophan and Tryptophol being most effective.

Treating hyperprolactinemia can help manage PCOS symptoms.

Defective protein folding due to a mutation is key in ANE syndrome.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.